Key points are not available for this paper at this time.
THCV could represent a new therapeutic agent in glycemic control in subjects with type 2 diabetes.
Jadoon et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: